My preferred result without knowing the boards full options is...

My preferred result without knowing the boards full options is when ODD is granted us/euro (hopefully), along with new indications etc that we can get a decent enough price rise and raise necessary funds for European trial partner free.

Now that ANP is not nearly on welfare with necessary "bank" negotiate a decent parntering deal for atl1103 for acromegaly. With that deal being enough to start trial in the US, if not raise more funds for US trial. Last option is to partner for US Atl1102 for DMD now from a position of strength. That's my best senario other then some pipe dream result.
I do agree with akki BETTER deals are done when you're not backed into a corner with a desperate need for funds, although that can be somewhat untrue if there is milultiple genuine PHARMA interest happening.
Anyone else have thoughts.
I hope everyone has a good weekend.